Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 13-week, double-blind, parallel group, multi-centre study to compare the bronchial anti-inflammatory activity of the combination of salmeterol/fluticasone propionate 50/500mcg twice daily compared with placebo twice daily in patients with Chronic Obstructive Pulmonary Disease (COPD)
fluticasone propionate/salmeterol
SCO30005
NCT00268177
Pulmonary Disease, Chronic Obstructive
Phase 3
 
September 2013

Powered by ideaPoint, Inc.